BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29350496)

  • 21. Alterations in procoagulant, anticoagulant, and fibrinolytic systems before and after start of induction chemotherapy in children with acute lymphoblastic leukemia.
    Albayrak M; Gürsel T; Kaya Z; Koçak U
    Clin Appl Thromb Hemost; 2013; 19(6):644-51. PubMed ID: 22751908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
    Stevenson HL; Prats MM; Sasatomi E
    BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N
    Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Yamamoto M; Hori T; Igarashi K; Iesato K; Saito M; Miyanishi K; Kikuchi N; Fujita H; Tsutsumi H
    Int J Hematol; 2018 Apr; 107(4):390-391. PubMed ID: 29181701
    [No Abstract]   [Full Text] [Related]  

  • 26. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
    Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
    J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.
    Felice MS; Rossi JG; Gallego MS; Alfaro EM; Zubizarreta PA; Fraquelli LE; Alonso CN; Guitter MR; Scopinaro MJ
    Pediatr Blood Cancer; 2011 Jul; 57(1):47-55. PubMed ID: 21394895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Appel IM; Hop WC; Pieters R
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification.
    McAtee CL; Schneller N; Brackett J; Bernhardt MB; Schafer ES
    Cancer Chemother Pharmacol; 2017 Dec; 80(6):1261-1264. PubMed ID: 29051993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Bancillon A
    Arch Fr Pediatr; 1991 Oct; 48(8):593-4. PubMed ID: 1768205
    [No Abstract]   [Full Text] [Related]  

  • 33. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.
    Bertaina A; Vinti L; Strocchio L; Gaspari S; Caruso R; Algeri M; Coletti V; Gurnari C; Romano M; Cefalo MG; Girardi K; Trevisan V; Bertaina V; Merli P; Locatelli F
    Br J Haematol; 2017 Feb; 176(4):629-636. PubMed ID: 28116786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.
    Akil A; Zhang Q; Mumaw CL; Raiker N; Yu J; Velez de Mendizabal N; Haneline LS; Robertson KA; Skiles J; Diaz-Ricart M; Carreras E; Renbarger J; Hanash S; Bies RR; Paczesny S
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1739-45. PubMed ID: 26172478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
    Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
    López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
    Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M; Matysiak M; Newecka-Samól T; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):350-3. PubMed ID: 1437752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.
    Kraemer DM; Waschke J; Kunzmann V; Wilhelm M
    Ann Hematol; 2003 Jul; 82(7):444-7. PubMed ID: 12761649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation profile during induction chemotherapy in childhood acute lymphoblastic leukemia.
    Sehgal S; Sharma S; Chandra J; Nangia A
    Indian J Pathol Microbiol; 2017; 60(1):50-56. PubMed ID: 28195091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.